Clinical Trials

Cardiogenic shock

Displaying 2 studies

A Study of Novel Biomarkers in Suspected Cardiogenic Shock Rochester, MN

The purpose of this study is to assess biomarkers of Cardiogenic Shock (CS) which may be associated with the development of and outcomes after CS to provide incremental prognostic information beyond the standard metrics for hospitalized patients with suspected cardiogenic shock.
A Study to Evaluate DDP3 as a Predictor of Cardiogenic Shock in Patients Presenting with Cardiac Symptoms Rochester, MN

The purpose of this study is to evaluate whether DDP3 identifies patients at early risk of cardiogenic shock presenting with STEMI in order to benefit from more aggressive cardiology scrutiny.